Where Will Kestra Medical Stock Be in 1 Year?
Kestra Medical Technologies (NASDAQ:KMTS) is a medical device startup that…
Buy
63
T Quote, Financials, Valuation and Earnings
Last price:
$28.29
Seasonality move
:
0.92%
Day range:
$27.80 - $28.30
52-week range:
$18.07 - $29.03
Dividend yield:
4%
P/E ratio:
17.04x
P/S ratio:
1.63x
P/B ratio:
1.93x
Volume:
51.5M
Avg. volume:
32.9M
1-year change:
53.26%
Market cap:
$199.8B
Revenue:
$122.3B
EPS (TTM):
$1.63
Analysts' Opinion
-
Consensus RatingAT&T has received a consensus rating of Buy. The company's average rating is a Buy based on 12 Buy ratings, 7 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $29.30, AT&T has an estimated upside of 5.5% from its current price of $28.20.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $17.80 representing 100% downside risk from its current price of $28.20.
Fair Value
-
According to the consensus of 20 analysts, AT&T has 5.5% upside to fair value with a price target of $29.30 per share.
T vs. S&P 500
-
Over the past 5 trading days, AT&T has underperformed the S&P 500 by -1.62% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
AT&T does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
AT&T has grown year-over-year revenues for 2 quarters straight. In the most recent quarter AT&T reported revenues of $30.6B.
Earnings Growth
-
AT&T has grown year-over-year earnings for 2 quarters straight. In the most recent quarter AT&T reported earnings per share of $0.61.
Enterprise value:
337.2B
EV / Invested capital:
1.36x
Price / LTM sales:
1.63x
EV / EBIT:
13.76x
EV / Revenue:
2.74x
PEG ratio (5yr expected):
--
EV / Free cash flow:
17.30x
Price / Operating cash flow:
10.28x
Enterprise value / EBITDA:
7.45x
Gross Profit (TTM):
$73.6B
Return On Assets:
2.99%
Net Income Margin (TTM):
9.64%
Return On Equity:
9.84%
Return On Invested Capital:
4.76%
Operating Margin:
20.43%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $121.2B | $122.3B | $122.9B | $30B | $30.6B | |
| Gross Profit | $70.7B | $72.6B | $73.6B | $18.1B | $18.6B | |
| Operating Income | $23.4B | $24.7B | $24.4B | $6B | $6.3B | |
| EBITDA | $20.5B | $44.9B | $45.2B | $11.6B | $12.8B | |
| Diluted EPS | -$1.27 | $1.86 | $1.63 | $0.47 | $0.61 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $62.8B | $76.9B | $29.9B | $30.4B | $33.8B | |
| Total Assets | $547B | $577.2B | $400.9B | $399.4B | $397.5B | |
| Current Liabilities | $76.6B | $82.5B | $58.2B | $44.8B | $48B | |
| Total Liabilities | $363.9B | $390.6B | $292.5B | $278.8B | $275.6B | |
| Total Equity | $183.1B | $186.6B | $108.3B | $120.6B | $121.8B | |
| Total Debt | $178.3B | $206.9B | $137.5B | $132.8B | $126.2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $33B | $39.2B | $40.3B | $7.5B | $9B | |
| Cash From Investing | -$17B | -$18.8B | -$19.5B | -$3B | -$5B | |
| Cash From Financing | -$51.7B | -$19.7B | -$17.4B | -$7.8B | -$553M | |
| Free Cash Flow | $13.6B | $21.9B | $19.5B | $3.8B | $4.8B | |
T
Sector
Market Cap
$199.8B
$84.8M
Price % of 52-Week High
95.66%
67.46%
Dividend Yield
4%
0%
Shareholder Yield
5.14%
3.76%
1-Year Price Total Return
53.34%
-7.14%
Beta (5-Year)
0.403
0.583
Dividend yield:
4%
Annualized payout:
$1.11
Payout ratio:
69.72%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$28.01
200-day SMA
Buy
Level
$24.55
Bollinger Bands (100)
Buy
Level
25.72 - 28.04
Chaikin Money Flow
Buy
Level
2.1B
20-day SMA
Buy
Level
$27.85
Relative Strength Index (RSI14)
Buy
Level
56.29
ADX Line
Buy
Level
10.61
Williams %R
Neutral
Level
-60.4317
50-day SMA
Buy
Level
$27.52
MACD (12, 26)
Buy
Level
0.14
25-day Aroon Oscillator
Buy
Level
68
On Balance Volume
Neutral
Level
2.6B
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.8219)
Sell
CA Score
(Annual)
Level (-1.1887)
Buy
Beneish M-Score
(Annual)
Level (-2.8488)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (-0.5694)
Buy
Piotroski F Score
(Annual)
Level (7)
Sell
Quality Ratio Score
Level (4)
Sell
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
The wireless business contributes nearly 70% of AT&T’s revenue. The firm is the third-largest US wireless carrier, connecting 73 million postpaid and 17 million prepaid phone customers. Fixed-line enterprise services, which account for about 15% of revenue, include internet access, private networking, security, voice, and wholesale network capacity. Residential fixed-line services, about 11% of revenue, primarily consist of broadband internet access, serving 14 million customers. AT&T also has a sizable presence in Mexico, with 24 million customers, but this business only accounts for 3% of revenue. The firm has agreed to sell its 70% equity stake in satellite television provider DirecTV to its partner, private equity firm TPG.
Stock Forecast FAQ
In the current month, T has received 12 Buy ratings 7 Hold ratings, and 1 Sell ratings. The T average analyst price target in the past 3 months is $29.30.
-
Where Will AT&T Stock Be In 1 Year?
According to analysts, the consensus estimate is that AT&T share price will rise to $29.30 per share over the next 12 months.
-
What Do Analysts Say About AT&T?
Analysts are divided on their view about AT&T share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that AT&T is a Sell and believe this share price will drop from its current level to $17.80.
-
What Is AT&T's Price Target?
The price target for AT&T over the next 1-year time period is forecast to be $29.30 according to 20 Wall Street analysts, 12 of them rate the stock a Buy, 1 rates the stock a Sell, and 7 analysts rate the stock a Hold.
-
Is T A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for AT&T is a Buy. 12 of 20 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of T?
You can purchase shares of AT&T via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase AT&T shares.
-
What Is The AT&T Share Price Today?
AT&T was last trading at $28.29 per share. This represents the most recent stock quote for AT&T. Yesterday, AT&T closed at $28.20 per share.
-
How To Buy AT&T Stock Online?
In order to purchase AT&T stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Howard Marks Buy Grab Stock?
When a legendary value investor who cut his teeth in…
Why Did Warren Buffett Buy Amazon Stock?
When investors think of tech stocks in Warren Buffett’s portfolio,…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 41x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
88
CDTX alert for Jun 24
Cidara Therapeutics [CDTX] is up 3.18% over the past day.
Sell
46
HIMS alert for Jun 24
Hims & Hers Health [HIMS] is up 2.26% over the past day.
Buy
67
WGS alert for Jun 24
GeneDx Holdings [WGS] is up 13.99% over the past day.
